PATIENTS WITH SOLID TUMORS RECEIVING IMMUNOTHERAPY WITH AN ICI WILL BE RANDOMIZED TO PARTICIPATE IN AN SDOH AND SIDE EFFECTS NAVIGATION PROGRAM VS. CONTROL
Clinical trials for PATIENTS WITH SOLID TUMORS RECEIVING IMMUNOTHERAPY WITH AN ICI WILL BE RANDOMIZED TO PARTICIPATE IN AN SDOH AND SIDE EFFECTS NAVIGATION PROGRAM VS. CONTROL explained in plain language.
Never miss a new study
Get alerted when new PATIENTS WITH SOLID TUMORS RECEIVING IMMUNOTHERAPY WITH AN ICI WILL BE RANDOMIZED TO PARTICIPATE IN AN SDOH AND SIDE EFFECTS NAVIGATION PROGRAM VS. CONTROL trials appear
Sign up with your email to follow new studies for PATIENTS WITH SOLID TUMORS RECEIVING IMMUNOTHERAPY WITH AN ICI WILL BE RANDOMIZED TO PARTICIPATE IN AN SDOH AND SIDE EFFECTS NAVIGATION PROGRAM VS. CONTROL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use